title: Management of oromandibular dystonia with botulinum A toxin: a series of cases.
abstract: Oromandibular dystonia is a disorder of movement that is often misdiagnosed. We present our experience of six patients treated with botulinum A toxin, for whom we recorded the symptoms, the group of muscles targeted, and the quantity of botulinum toxin used. We used the Glasgow Benefit Inventory (GBI) questionnaire to record and analyse outcomes after treatment. Five of the six patients had a good outcome as recorded by the GBI, the mean (SD) score of which was +40 (28), which reflected that the patients were well satisfied. The overall improvement in the categories of general health, social health, and physical health were 82%, 37%, and 31%, respectively. Botulinum type A toxin is an effective treatment of oromandibular dystonia. It is important for clinicians to recognise the condition, as treatment is well-tolerated and can improve quality of life.
authors: Leeds Teaching Hospitals NHS Trust, Leeds Dental Institute, Clarendon Way, Leeds LS2 9LU, United Kingdom. Electronic address: trevor.teemul@nhs.net.
authors: T A
authors: TA
authors: Teemul
authors: Leeds Teaching Hospitals NHS Trust, Leeds Dental Institute, Clarendon Way, Leeds LS2 9LU, United Kingdom. Electronic address: radhe.patel359@gmail.com.
authors: R
authors: R
authors: Patel
authors: Leeds Teaching Hospitals NHS Trust, Leeds Dental Institute, Clarendon Way, Leeds LS2 9LU, United Kingdom. Electronic address: a.kanatas@doctors.org.uk.
authors: A
authors: A
authors: Kanatas
authors: Leeds Teaching Hospitals NHS Trust, Leeds Dental Institute, Clarendon Way, Leeds LS2 9LU, United Kingdom. Electronic address: lachlan.carter@nhs.net.
authors: L M
authors: LM
authors: Carter
mesh_terms: D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D004421:Dystonia / Q000188:drug therapy*; D006801:Humans; D009465:Neuromuscular Agents / Q000627:therapeutic use*; D011788:Quality of Life; D011795:Surveys and Questionnaires; D016896:Treatment Outcome
chemical_list: D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A
keywords: Botulinum A toxin; Meige syndrome; Oromandibular Dystonia